Anika Therapeutics Inc (ANIK) Insider Trading
- $574,745.50
- $57,064,246.57
- May 11, 2022
- Charles H Sherwood
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 11, 2022 | EVP | 1,500 | $21.37 | Buy | $32,055.00 | |
| March 14, 2022 | EVP | 1,500 | $26.65 | Buy | $39,975.00 | |
| March 11, 2022 | CEO | 8,100 | $25.57 | Buy | $207,117.00 | |
| March 11, 2022 | Director | 2,000 | $24.66 | Buy | $49,320.00 | |
| March 11, 2022 | CFO | 4,000 | $24.62 | Buy | $98,480.00 | |
| Aug. 11, 2021 | CFO | 2,850 | $40.21 | Buy | $114,598.50 | |
| May 12, 2021 | Director | 2,000 | $42.60 | Sell | $85,200.00 | |
| July 9, 2020 | EVP | 1,244 | $35.15 | Sell | $43,726.60 | |
| Feb. 26, 2020 | Director | 2,700 | $42.68 | Sell | $115,236.00 | |
| Nov. 8, 2019 | CFO | 20,000 | $59.71 | Sell | $1,194,200.00 | |
| Aug. 28, 2019 | Director | 4,355 | $57.21 | Sell | $249,149.55 | |
| Aug. 20, 2019 | Director | 1,994 | $55.57 | Sell | $110,806.58 | |
| Aug. 8, 2019 | Director | 4,843 | $56.66 | Sell | $274,404.38 | |
| July 29, 2019 | Director | 3,000 | $55.44 | Sell | $166,320.00 | |
| Feb. 28, 2019 | CEO | 1,000 | $33.20 | Buy | $33,200.00 | |
| Feb. 26, 2019 | Director | 4,000 | $33.06 | Sell | $132,240.00 | |
| Nov. 30, 2017 | Insider | 5,250 | $54.48 | Sell | $286,020.00 | |
| Oct. 23, 2017 | CEO | 22,228 | $60.06 | Sell | $1,335,013.68 | |
| Oct. 20, 2017 | CEO | 5,991 | $60.04 | Sell | $359,699.64 | |
| Oct. 16, 2017 | CEO | 3,293 | $60.04 | Sell | $197,711.72 | |
| Oct. 13, 2017 | CEO | 7,124 | $60.08 | Sell | $428,009.92 | |
| July 27, 2017 | CEO | 63,799 | $50.79 | Sell | $3,240,351.21 | |
| July 5, 2017 | CEO | 14,201 | $50.03 | Sell | $710,476.03 | |
| May 22, 2017 | Director | 10,725 | $47.39 | Sell | $508,257.75 | |
| Nov. 9, 2016 | Director | 540 | $43.39 | Sell | $23,430.60 | |
| Feb. 25, 2016 | Director | 2,695 | $43.62 | Sell | $117,555.90 | |
| Feb. 27, 2015 | Director | 4,621 | $39.49 | Sell | $182,483.29 | |
| May 1, 2014 | CEO | 83,780 | $44.32 | Sell | $3,713,129.60 | |
| Feb. 28, 2014 | CEO | 200,000 | $41.70 | Sell | $8,340,000.00 | |
| Aug. 22, 2013 | Director | 5,000 | $24.35 | Sell | $121,750.00 | |
| Aug. 8, 2013 | Director | 26,984 | $23.61 | Sell | $637,092.24 | |
| Aug. 7, 2013 | Director | 11,016 | $27.01 | Sell | $297,542.16 | |
| Aug. 6, 2013 | Major Shareholder | 1,270,000 | $24.52 | Sell | $31,140,400.00 | |
| July 15, 2013 | CEO | 75,000 | $20.11 | Sell | $1,508,250.00 | |
| July 9, 2013 | CEO | 49,185 | $18.06 | Sell | $888,281.10 | |
| July 5, 2013 | CEO | 34,662 | $18.01 | Sell | $624,262.62 | |
| June 19, 2013 | CEO | 1,847 | $18.00 | Sell | $33,246.00 |
Insiders are both buying and selling Anika Therapeutics Inc stock.
The insider traders at Anika Therapeutics Inc are: Charles H Sherwood, Raymond J Land, Jeffery S Thompson, Michael L Levitz, David Colleran, Steve E Wheeler, Joseph G Darling, Joseph I Bower, Joseph L Bower, Richard Hague, Sylvia Cheung, Cheryl R Blanchard, Farmaceutici S.P.A. Fidia, Glenn R Larsen, James Loerop, and John C Moran
The most active insider trader at Anika Therapeutics Inc is Charles H Sherwood with 12 trades.
Farmaceutici S.P.A. Fidia has sold the most Anika Therapeutics Inc stock with a total value of $62,280,800.00.
Cheryl R Blanchard has bought the most Anika Therapeutics Inc stock with a total value of $414,234.00.
The most recent insider trade for Anika Therapeutics Inc was on May 11, 2022.
The single biggest insider buy for Anika Therapeutics Inc was from Cheryl R Blanchard with a total value of $207,117.00 on March 11, 2022.
The single biggest insider sell for Anika Therapeutics Inc was from Farmaceutici S.P.A. Fidia with a total value of $31,140,400.00 on Aug. 6, 2013.